empty

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for all severities of plaque psoriasis in adults.

Manufacturer Leo says that “more than half of patients in clinical trials [experience] significant visible signs of improvement within four weeks with some patients seeing improvements at one week”. In addition, 81 per cent of psoriasis patients using Enstilar foam spray reported improved quality of life after four weeks. More than 70 per cent reported reductions in itch-related
sleep loss.

“The symptomatic relief experienced by the majority of patients may be attributed to the cooling effect of the new foam spray,” Leo says.

Recommended

Clinical review: Antihypertensive medication

NICE recommends Tremfya




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.